medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2022, Number 6

<< Back

Rev Mex Urol 2022; 82 (6)

Inflammatory myofibroblastic tumor. An aggressive case report

Ayerra-Pérez H, Herrera-Aranda N, Iglesias-Martínez E, Extramiana-Cameno J

Language: Spanish
References: 15
Page:
PDF size: 275.12 Kb.


ABSTRACT

Clinic case: We present an extraordinary case report from a male diagnosed with Inflammatory Myofibroblastic Tumors (IMT) after suddenly presenting with a haemorrhagic shock due to hematuria. He underwent a partial cystectomy to achieve the complete resection and confirm the pathologic diagnosis. After the complete resection, he is free of relapse.
Relevance: Our case report shows an extraordinary aggressiveness and a life-threatening disease course. The final pathologic exam confirmed the diagnosis and reported the pathologic correlation with the radiological findings of such an infrequent entity.
Clinical implications: Although infrequent, IMT might present aggressively. After the initial clinical and radiological suspicion, finding must be confirmed by the complete resection and the pathologic exam.
Conclusion: The early diagnosis enables the complete resection of the tumor, which is the most determinant prognostic factor. Selected patients with unresectable lesions might also benefit from adjuvant treatment with ALK-inhibitors.


REFERENCES

  1. Inflammatory myofibroblastic tumors ofthe genitourinary tract--single entity orcontinuum? J Urol. 2008;180(4):1235–40. doi:https://doi.org/10.1016/j.juro.2008.06.049

  2. Mincik I, Mytnik M, Straka L, Breza J, VilchaI. Inflammatory pseudotumour of urinarybladder - a rare cause of massive macroscopichaematuria. Bratisl Lek Listy. 2013;114(9):495–7. doi: https://doi.org/10.4149/bll_2013_103

  3. Chung VCH, Ma PHX, Lau CH, Wong SYS, YeohEK, Griffiths SM. Views on traditional Chinesemedicine amongst Chinese population: asystematic review of qualitative and quantitativestudies. Health Expectations. 2014;17(5):622–36. doi: https://doi.org/10.1111/j.1369-7625.2012.00794.x

  4. Forrest A, Numbere N, Jean-Gilles J, DograV. Sonographic Evaluation of GenitourinaryInflammatory Pseudotumors and Its Mimics.Ultrasound Q. 2019;37(4):298–307. doi: https://doi.org/10.1097/ruq.0000000000000468

  5. Rosado E, Pereira J, Corbusier F, DemeterP, Bali MA. Inflammatory pseudotumorof the urinary bladder. J Radiol Case Rep.2015;9(1):36–42. doi: https://doi.org/10.3941/jrcr.v9i1.2066

  6. Cruz P, Ramírez M, Iborra I, Rubio J, PintoF, Gómez-Ferrer A, et al. Adenocarcinomade uraco: ¿qué tanto sabemos? Rev MexUrol. 2014;74(5):301–7. doi: https://doi.org/10.1016/j.uromx.2014.09.002

  7. Teoh JYC, Chan N-H, Cheung H-Y, Hou SSM,Ng C-F. Inflammatory myofibroblastic tumorsof the urinary bladder: a systematic review.Urology. 2014;84(3):503–8. doi: https://doi.org/10.1016/j.urology.2014.05.039

  8. Baldi GG, Brahmi M, Lo Vullo S, CojocaruE, Mir O, Casanova M, et al. The Activity ofChemotherapy in Inflammatory MyofibroblasticTumors: A Multicenter, EuropeanRetrospective Case Series Analysis. Oncologist.2020;25(11):e1777–84. doi: https://doi.org/10.1634/theoncologist.2020-0352

  9. Coffin CM, Patel A, Perkins S, Elenitoba-JohnsonKS, Perlman E, Griffin CA. ALK1 and p80expression and chromosomal rearrangementsinvolving 2p23 in inflammatory myofibroblastictumor. Mod Pathol. 2001;14(6):569–76. doi:https://doi.org/10.1038/modpathol.3880352

  10. Nagumo Y, Maejima A, Toyoshima Y,Komiyama M, Yonemori K, Yoshida A, et al.Neoadjuvant crizotinib in ALK-rearrangedinflammatory myofibroblastic tumor of theurinary bladder: A case report. InternationalJournal of Surgery Case Reports. 2018;48:1–4.doi: https://doi.org/10.1016/j.ijscr.2018.04.027

  11. Zhou J, Jiang G, Zhang D, Zhang L, Xu J, Li S,et al. Epithelioid inflammatory myofibroblasticsarcoma with recurrence after extensiveresection: significant clinicopathologiccharacteristics of a rare aggressive softtissue neoplasm. Int J Clin Exp Pathol.2015;8(5):5803–7.

  12. Sbaraglia M, Bellan E, Tos APD. The 2020WHO Classification of Soft Tissue Tumours:news and perspectives. Pathologica - Journal ofthe Italian Society of Anatomic Pathology andDiagnostic Cytopathology. 2021;113:70–84. doi:https://doi.org/10.32074/1591-951x-213

  13. Song D, Jiao W, Gao Z, Liu N, Zhang S, ZongY, et al. Inflammatory myofibroblastic tumorof urinary bladder with severe hematuria: ACase report and literature review. Medicine.2019;98(1):e13987. doi: https://doi.org/10.1097/md.0000000000013987

  14. Coffin CM, Hornick JL, Fletcher CDM.Inflammatory myofibroblastic tumor:comparison of clinicopathologic, histologic, andimmunohistochemical features including ALKexpression in atypical and aggressive cases. AmJ Surg Pathol. 2007;31(4):509–20. doi: https://doi.org/10.1097/01.pas.0000213393.57322.c7

  15. Libby EK, Ellis LT, Weinstein S, HammerRD, Murray KS. Metastatic inflammatorymyofibroblastic tumor of the bladder. UrologyCase Reports. 2019 Mar 1;23:10–2. doi: https://doi.org/10.1016/j.eucr.2018.11.007




2020     |     www.medigraphic.com